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A nationwide survey of prophylaxis against
ophthalmia neonatorum in Turkey
Aim: To analyze the current practice of neonatal conjunctivitis (ophthalmia neonatorum) prophylaxis
in Turkey.
Materials and methods: A standard questionnaire that collected information regarding the name and
location of the clinical setting, the name and dosage of the medication used to prevent neonatal
conjunctivitis (if there was any), and the department and preference concerning which health workers
should administer the agent (gynecologist, pediatrician, or midwife) was prepared and administered
to 24 university hospitals as well as to 24 registered community hospitals that had both pediatric and
obstetric units.
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Results: Neonatal conjunctivitis prophylaxis was administered by 58.3% of the respondents
(university hospitals [66.7%] and community hospitals [50%]). The 2 most frequently used substances
were gentamycin 18/28 (64.3%) and tobramycin 4/28 (8.3%). Other substances were tetracycline,
silver nitrate, povidone-iodine, bacitracin + neomycin, and penicillin G.
Conclusion: A nationwide consensus on the clinical department that should be involved, which
health workers should administer the agent (gynecologist, pediatrician, or midwife), and which
substance should be used for ophthalmia neonatorum prophylaxis must be reached. By using a
similar survey other countries may also assess their current situation, and decrease the occurrence
of neonatal conjunctivitis and neonatal blindness by administering the appropriate substances.
Key words: Gentamycin, neonatal conjunctivitis, ophthalmia neonatorum, povidone-iodine,
prophylaxis

Türkiye genelinde neonatal konjonktivit proflaksisi hakkında anket
Amaç: Türkiye’de neonatal konjonktivit proflaksisinde mevcut durumu analiz etmek.
Yöntem ve gereçler: Kadın doğum ve pediatri kliniğinin her ikisini de içeren 24 üniversite ve 24
devlet hastanesine neonatal konjonktivit proflaksisi uygulayan klinik, uygulanan ilaç (eğer varsa
dozu) ve hangi sağlık çalışanın (kadın hastalıkları ve doğum hekimi, çocuk hastalıkları hekimi veya
ebe) uygulama yaptığına dair bir anket hazırlanarak uygulandı.
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Bulgular: Neonatal konjonktivit proflaksisi ortalama olarak % 58,3 oranında (üniversite hastaneleri
% 66,7 ve devlet hastaneleri % 50) uygulanmakta idi. En sık kullanılan iki ilaç gentamisin 18/28 (%
64,3) ve tobramisin 4/28 (% 8,3) idi. Diğer kullanılan ilaçlar ise tetrasiklin, gümüş nitrat, povidoniyot, basitrasin + neomisin ve penisilin G idi.
Sonuç: Ülke genelinde oftalmia neonatarum proflaksisinde hangi klinik departmanın, hangi sağlık
çalışanının (kadın hastalıkları ve doğum hekimi, çocuk hastalıkları hekimi veya ebe) ve hangi ilacın
kullanılacağı konusunda bir fikir birliği gerektiğini düşünmekteyiz. Diğer ülkeler de böyle bir anketle
mevcut durumu belirleyerek uygun antibiyotiklerin kullanımı ile neonatal konjonktivit ve neonatal
körlük sıklığını azaltabilirler.
Anahtar sözcükler: Gentamisin, neonatal konjonktivit, oftalmia neonatarum, povidon-iyot, proflaksi
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Introduction

Results

Ophthalmia neonatorum is a form of
conjunctivitis that can occur during the first month of
life due to various etiological factors, including
Neisseria gonorrhoeae, Chlamydia trachomatis,
viruses, and chemicals (1). During the 19th century the
single greatest cause of blindness in newborns in
Western countries was gonorrheal keratitis, until
Crede introduced the use of 2% silver nitrate
ophthalmic solution to the eyes of newborns (2). With
the use of this prophylaxis the incidence of neonatal
conjunctivitis was reduced significantly. With the
development of new antibiotics, neonatal
conjunctivitis is no longer a major health problem in
developed countries.

Neonatal conjunctivitis prophylaxis was
administered by 58.3% of all respondents (university
hospitals [66.7%] and community hospitals [50%], P
= 0.38). There was not a preferred method or
antibiotic used for prophylaxis, for vaginal delivery or
caesarian section, in both groups of hospitals.
Pediatric clinics and pediatricians were mainly
responsible for the prophylaxis of neonatal
conjunctivitis in both university and community
hospitals (Figures 1 and 2).

Materials and methods
A standard questionnaire was prepared and
administered to 24 university hospitals and 24
registered community hospitals that have both
pediatric and obstetric units. The questionnaire
collected data about the name and location of the
clinical setting, the name and dosage of the
medication used to prevent neonatal conjunctivitis (if
there was any), and the department and preference
concerning which health workers should administer
the agent (gynecologist, pediatrician, or midwife).
The study complied with the tenets of the Declaration
of Helsinki. For statistical analysis the chi-square test
was used to compare groups. P < 0.05 was considered
statistically significant.
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There are limited data about the prophylactic
programs in Turkish hospitals for the prevention of
neonatal conjunctivitis. In addition, guidelines for a
national standardized prophylactic program for
neonatal conjunctivitis in Turkey are lacking. As such,
we sought to analyze the current practice of neonatal
conjunctivitis (ophthalmia neonatorum) prophylaxis
in Turkey.
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Figure 1. Pediatric clinics were primarily responsible for
prophylaxis of neonatal conjunctivitis, in both university
and community hospitals.
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Although silver nitrate has a broad antimicrobial
spectrum, its effectiveness against chlamydia is
limited. Chlamydia, which was one of the most
important causes of neonatal conjunctivitis in the
past, today remains a current health issue. In many
countries other drugs used for this prophylactic
purpose include erythromycin, tetracycline,
gentamycin, and povidone-iodine (3-7).

The 2 most frequently administered substances
were gentamycin 18/28 (64.3%) and tobramycin 4/28
(8.3%). Other substances used were tetracycline, silver
nitrate, povidone-iodine, bacitracin + neomycin, and
penicillin G. Figure 3 shows the use of substances in
the hospital groups. All of the clinics administered
antibiotics once on the first postnatal day; none
administered antibiotics twice.
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Figure 2. The health workers in charge of administrating
prophylaxis in the study hospitals.
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Figure 3. The number of substances used for prophylaxis in the
study hospitals.
Gn: Gentamycin; Tob: tobramycin; T: terramycin; P:
penicillin; SN: silver nitrate; BN: bacitracin + neomycin.

Discussion
Socioeconomic flaws as well as a lack of national
guidelines for prophylaxis of ophthalmia neonatorum
play a major role in developing countries. One of the
most commonly used substances for neonatal
conjunctivitis prophylaxis in hospitals in developing
countries is 2.5% povidone-iodine ophthalmic
solution (5,8). The efficacy of povidone-iodine was
reported to be significantly higher than no
prophylaxis (9), erythromycin (8,10), or silver nitrate
(8) for prophylaxis of neonatal conjunctivitis.
Povidone-iodine was also reported to be less toxic to
the eye than silver nitrate and erythromycin (8), and
to have no adverse effects on thyroid-stimulating
hormone levels or renal iodine excretion in newborns
(10). Unfortunately, povidone-iodine was not used in
any hospital included in the present study.
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In the current study we observed that there was no
consensus in major hospitals regarding prophylaxis
against ophthalmia neonatorum. Neonatal
conjunctivitis prophylaxis was administered by 66.7%
of university hospitals and 50% of community
hospitals; the other hospitals that responded to the
survey did not use prophylaxis, and the difference was
not statistically significant (P = 0.38). Additionally,
the substances used for prophylaxis showed
heterogeneity. Assadian et al. (11) also reported that
the methodology of prophylaxis and the substances
used in Austria showed heterogeneity. Both
pediatricians and obstetricians may play a major role
and they should reach a consensus on the substance or
method of prophylaxis, so as to avoid any mix ups or
discrepancies in administration. There must also be a
consensus among doctors, nurses, and midwives.
In Turkey there are limited data available regarding
ophthalmia neonatorum prophylaxis, as well as the
lack of a national guideline. A nationwide agreement
for ophthalmia neonatorum prophylaxis in Turkey is
necessary in order to change the current routine, and
to decrease neonatal conjunctivitis and neonatal
blindness. At this point, povidone-iodine is promising
and deserves serious consideration in the prophylactic
treatment against ophthalmia neonatorum in
developing countries, because of its efficacy, low cost,
and availability. Using a similar survey other countries
can also assess their current situation and develop a
nationwide consensus on how to decrease neonatal
conjunctivitis and neonatal blindness.
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